Altometrixs LLC is categorized under Wholesale Pharmaceutical Products in Hoboken, NJ and active since 2010.
Altometrixs LLC was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Stephen Logano at the company’s single location by writing to 931 Bloomfield St, Hoboken, New Jersey NJ 07030 or by phoning (973) 476-5109. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Altometrixs LLC |
| Contact Person: | Stephen Logano |
| Address: | 931 Bloomfield St, Hoboken, New Jersey 07030 |
| Phone Number: | (973) 476-5109 |
| Website Address: | altometrixs.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Altometrixs LLC was started in 2010 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Stephen Logano for inquiries that concern Altometrixs LLC by calling the company number (973) 476-5109, as your correspondence is most welcome. Additionally, the physical location of the single location of Altometrixs LLC can be found at the coordinates 40.748071,-74.028335 as well as the street address 931 Bloomfield St in Hoboken, New Jersey 07030.
For its online presence, you may visit Altometrixs LLC’s website at altometrixs.com and engage with its social media outlets through on Twitter and on Facebook.